Chemoinformaics analysis of D-ALANYL-GLYCINE
Molecular Weight | 182.607 | nRot | 3 |
Heavy Atom Molecular Weight | 171.519 | nRig | 2 |
Exact Molecular Weight | 182.046 | nRing | 0 |
Solubility: LogS | -0.194 | nHRing | 0 |
Solubility: LogP | -2.766 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 22.4707 |
nHD | 3 | BPOL | 13.2813 |
QED | 0.453 |
Synth | 2.42 |
Natural Product Likeliness | -0.195 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.041 |
HIA | 0.007 |
CACO-2 | -6.233 |
MDCK | 0.00427491 |
BBB | 0.495 |
PPB | 0.0824457 |
VDSS | 0.284 |
FU | 0.899069 |
CYP1A2-inh | 0.007 |
CYP1A2-sub | 0.034 |
CYP2c19-inh | 0.054 |
CYP2c19-sub | 0.054 |
CYP2c9-inh | 0.037 |
CYP2c9-sub | 0.111 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.184 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.026 |
CL | 2.931 |
T12 | 0.774 |
hERG | 0.022 |
Ames | 0.028 |
ROA | 0.024 |
SkinSen | 0.188 |
Carcinogencity | 0.03 |
EI | 0.072 |
Respiratory | 0.139 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.934807 |